Diadema Partners LP 89bio, Inc. Transaction History
Diadema Partners LP
- $328 Billion
- Q2 2025
A detailed history of Diadema Partners LP transactions in 89bio, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 98,382 shares of ETNB stock, worth $1.46 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
98,382
Previous 231,436
57.49%
Holding current value
$1.46 Million
Previous $1.68 Billion
42.58%
% of portfolio
0.29%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
208Shares Held
160MCall Options Held
259KPut Options Held
1.57M-
Janus Henderson Group PLC London, X020.8MShares$308 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$295 Million4.27% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$211 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$141 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.05MShares$120 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $690M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...